ZYXI News and Press, Zynex Inc. From 05/12/20

Many investors tend to stay away from stocks that are appreciating strongly over time, mostly because of fears of buying too late when the stock is already overvalued. Having some patience when looking for entry prices and being conscious about valuation is very important. However, blindly avo...

Zynex ( ZYXI ) order growth is slowing down relative to the triple-digit rates in January and February due to the COVID-19 pandemic impact, but it is a temporary setback and these orders are still running at 50%+ levels above last year even with that headwind and the effect on revenue is smoot...

Image source: The Motley Fool. Zynex, Inc   (NASDAQ: ZYXI) Q1 2020 Earnings Call Apr 28, 2020 , 4:15 p.m. ET Operator Continue reading

Zynex, Inc. (ZYXI) Q1 2020 Earnings Conference Call April 28, 2020 04:15 PM ET Company Participants Thomas Sandgaard - Founder, Chairman and CEO Dan Moorhead - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Yi Chen - HC Wainwright Marc Wiesenberger - ...

Zynex (NASDAQ: ZYXI ): Q1 GAAP EPS of $0.09 beats by $0.03 . More news on: Zynex, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

ENGLEWOOD, Colo. , April 28, 2020 /PRNewswire/ --  Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostic...

ENGLEWOOD, Colo., April 21, 2020 /PRNewswire/ --  Zynex, Inc.  (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological di...

One of the trends in the first quarter of 2020 has been the significant underperformance of small-cap equities as a market segment amid the extreme levels of volatility. For context, the iShares Russell 2000 ETF ( IWM ) is down about 25% compared to a 13% decline in the S&P 500 Index ( S...

Zynex ( ZYXI +10.4% ) reports 126% Y/Y order growth in Q1 and 3% sequentially growth. More news on: Zynex, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

ENGLEWOOD, Colo. , April 7, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, to...